Xgeva 120 mg/1.7 mL injection Images

Generic Name: denosumab

This medication has been identified as Xgeva 120 mg/1.7 mL injection. It is supplied by Amgen Inc.

Xgeva is used in the treatment of Osteolytic Bone Metastases of Solid Tumors; Giant Cell Tumor of Bone; Osteolytic Bone Lesions of Multiple Myeloma; Hypercalcemia of Malignancy and belongs to the drug class miscellaneous bone resorption inhibitors. Not for use in pregnancy. Xgeva 120 mg/1.7 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Xgeva

Generic Name

denosumab

Strength

120 mg/1.7 mL injection

Availability

Prescription only

Drug Class

Miscellaneous bone resorption inhibitors

Pregnancy Category

X - Not for use in pregnancy

CSA Schedule

Not a controlled drug

Labeler / Supplier

Amgen Inc.

National Drug Code (NDC)

55513-0730

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer